Overview
Why was this study conducted?
The main goal of this study was to see if a combined diphtheria, tetanus, and whooping cough
vaccine (Tdap vaccine) when given to pregnant women can help to protect their babies.
What was studied? Who was in this study?
The study looked at, 687 healthy pregnant women 18 to 45
years old. The study was done in
Bodyâ€™s defenses (called antibodies)
Australia, Canada, Czechia, Finland, Italy
in pregnant women and in
and Spain.
newborns.
Safety of vaccinating pregnant
women (for both mother and baby).
What kind of study was it? Main results
Randomized: pregnant women were Pregnant mothers who got the Tdap
assigned by chance to receive either vaccine passed more antibodies
the Tdap vaccine or a placebo. against whooping cough to their
Observer-blinded: neither the study babies than those who got placebo.
doctors nor the pregnant women Results suggest that the Tdap vaccine
knew if they received the vaccine or was safe both for mothers and their
the placebo. babies.
Phase IV study: the Tdap vaccine is
available in the market.
NCT number: NCT02377349
EudraCT number: 2014-001119-38